This website uses cookies to enhance the user experience.
||
N

NORTH MURRAY AS987 622 415

Limited company
Henrik Ibsens gate 100 0255 OSLO, Norge

NORTH MURRAY AS

Operating
Å drive investeringsvirksomhet, herunder å investere i og delta i andre selskaper med et hvilket som helst formål.

Organization

Chairman of the board
Years since formation
20 years
since Jan 5, 2005
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
500
3 share classes
Total number of shareholders
6
4 companies, 2 persons
Belongs to group of

Financials

Annual total result 2024
-8,409,496
NOK
Total equity 2024
79,094,035
NOK
Last update: Nov 12, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO
45.08 %
directly 45 %
indirectly 0.08 %

Board

NameRoleShares
Chairman
45.08 %
directly 45 %
indirectly 0.08 %
Board Member-
Board Member-
Alternate Member
10.99 %
indirectly
Alternate Member-

Others

NameRoleShares
B
BHL AS
Auditor-
H
HÆGLAND & SVANBERG AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Chairman
45.08 %
directly 45 %
indirectly 0.08 %
Alternate Member
10.99 %
indirectly
-
10.99 %
indirectly
-
10.99 %
indirectly
Last update: Jul 8, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Class B shares
215
43 %
E
EDGE HOLDING AS
Class B shares
110
22 %
W
WHITE MOUNTAIN AS
C-shares
55
11 %
W
WHITE MONSTER AS
C-shares
55
11 %
W
WHITE FACE MOUNTAIN AS
C-shares
55
11 %
A-shares
10
2 %

Shares owned by the NORTH MURRAY AS

NameShare classTotal number of sharesShare
H
HERKULES CAPITAL V AS
Ordinary shares
3,000
100 %
A
ADNUNTIUS AS
Ordinary shares
7,800
64.12 %
G
GMT CAPITAL AS
Closed
Ordinary shares
400
40 %
A
AMICOAT AS
NO0010799679
11,878,671
30.92 %
M
MENTIS CURA AS
Closed
Ordinary shares
1,370,556
21.15 %
I
IL PANTHEON 2 AS
Under liquidation
Ordinary shares
2,728
5 %
P
PHARMASUM THERAPEUTICS AS
Ordinary shares
76,930
2.43 %
T
THE VELIXIO GROUP AS
Closed
NO0010863210
500,000
0.18 %
B
BRAND FOODS AS
Closed
Ordinary shares
41,639
0.05 %
P
PIXOTOPE TECHNOLOGIES AS
NO0010740749
415
< 0.01 %
L
LYTIX BIOPHARMA AS
NO0010405780
396
< 0.01 %
Last update: Jun 2, 2025

Group structure

  • Total operating income 2024: NOK 0
    Operating profit 2024: NOK -7,115,219
    Employees: 0

Financials

in NOK

Summary

Year2024202320222021
Total operating income
0
0
6,000
257,850
Annual Total Result
-8,409,496
118,825,424
-21,575,581
-38,566,506
Total assets
148,324,767
163,473,758
283,066,228
288,457,394
Total liabilities
69,230,732
62,158,666
300,576,559
264,392,144
Total equity
79,094,035
101,315,092
-17,510,331
24,065,250

P&L

Year2024202320222021
Total operating income
0
0
6,000
257,850
Total operating costs
7,115,219
8,424,466
8,196,867
17,378,226
Operating result
-7,115,219
-8,424,466
-8,190,867
-17,120,376
Financial income/costs
-1,294,278
131,028,783
-15,614,360
-21,446,131
Profit before tax
-8,409,496
122,604,317
-23,805,227
-38,566,506
Total tax & extraordinary income/cost
0
3,778,893
-2,229,646
0
Annual Total Result
-8,409,496
118,825,424
-21,575,581
-38,566,506

Balance overview

Year2024202320222021
Total fixed assets
146,246,071
148,379,018
261,851,765
267,711,997
Total current assets
2,078,696
15,094,740
21,214,463
20,745,396
Total assets
148,324,767
163,473,758
283,066,228
288,457,394
Short term debt
69,230,732
62,158,666
77,131,092
49,437,489
Long term debt
0
0
223,445,468
214,954,655
Total liabilities
69,230,732
62,158,666
300,576,559
264,392,144
Contributed capital
1,778,769
1,778,769
1,778,769
1,778,769
Retained earnings
77,315,266
99,536,323
-19,289,100
22,286,481
Total equity
79,094,035
101,315,092
-17,510,331
24,065,250
Total equity and liabilities
148,324,767
163,473,758
283,066,228
288,457,394

Classification

21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises